Vyrex Corporation Announces Launch of Its New Website.Business Editors/Science Writers LA JOLLA, Calif.--(BUSINESS WIRE)--May 11, 2004 Vyrex Corporation (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :VYRX) is pleased to announce the launch of its new website which is available for viewing at www.vyrex.com. In addition to the Vyrex overview, news and contact information, the website features updated information regarding its proprietary pharmaceutical, nutraceutical and cosmeceutical cos·me·ceu·ti·cal n. A cosmetic that has or is purported to have medicinal properties. technologies. Pharmaceutical product candidates: Neuprox(TM) (propofol phosphate), a unique drug candidate targeting the nervous system; Panavir(R), a drug candidate for viral diseases and cardiovascular disorders; and Vantox(R), a novel therapy for respiratory disorders. Nutraceutical products: ProFlavones(TM), novel nutraceuticals for cardiovascular, skeletal and cellular health. ProFlavones(TM) are novel delivery forms of isoflavones isoflavones (īˑ·sō·flāˈ·vōnz), n.pl phytoestrogenic compounds found in various plants, including red clover and soy. . Isoflavones are chemicals (phytochemicals) found in various edible beans, particularly soy, that have been shown to have estrogenic, anti-atherogenic, anti-carcinogenic and anti-osteoporotic activities. Recently, certain isoflavones have also been shown to be protective against ionizing radiation i·on·i·zing radiation n. High-energy radiation capable of producing ionization in substances through which it passes. Ionizing radiation (radioprotectants). Radioprotectants have applications in oncology, space travel, radiological terrorism and military scenarios. Vyrex has synthesized and is developing several isoflavone i·so·fla·vone n. A flavonoid found in soy. isoflavone 3-phenyl-4H-1-benzopyran-4-one; many of the naturally occurring estrogenic substances in pasture plants are isoflavones. prodrug prodrug /pro·drug/ (-drug) a compound that, on administration, must undergo chemical conversion by metabolic processes before becoming an active pharmacological agent; a precursor of a drug. forms that have potential nutraceutical, cosmeceutical and pharmaceutical applications. A high priority for Vyrex is the testing of its ProFlavones(TM) for radioprotective activity. ProMinerals(TM) are Vyrex's proprietary mineral transport delivery systems targeted for metabolic health, bone and joint health, cardiovascular health, visual health and gastrointestinal health. Cosmeceutical products: CosmoFlavone(TM) is a novel proprietary cosmeceutical agent Vyrex is developing from its ProFlavone(TM) technology to take advantage of the many activities of isoflavones that would potentially help protect the skin against aging. These activities include phytoestrogenic, antioxidant antioxidant, substance that prevents or slows the breakdown of another substance by oxygen. Synthetic and natural antioxidants are used to slow the deterioration of gasoline and rubber, and such antioxidants as vitamin C (ascorbic acid), butylated hydroxytoluene , anti-inflammatory, anti-angiogenic, radioprotective and ultraviolet protective actions. CarnoCopper(TM) is a novel antioxidant and skin repair cosmeceutical. CarnoCopper(TM) weds copper to the dipeptide di·pep·tide n. A peptide that, on hydrolysis, yields two amino acid molecules. carnosine. Copper is crucial for the synthesis of the most important elements of the skin, elastin elastin /elas·tin/ (e-las´tin) a yellow scleroprotein, the essential constituent of elastic connective tissue; it is brittle when dry, but when moist is flexible and elastic. e·las·tin n. and collagen, and carnosine which is found in human muscle, the nervous system and other tissues, is a potent antioxidant, buffer and mineral transporter. Vyrex Corporation is a La Jolla, Calif. based Biopharmaceutical Company seeking to discover and develop pharmaceutical, nutraceutical and cosmeceutical products for the treatment and prevention of respiratory, cardiovascular and neurodegenerative diseases neurodegenerative diseases diseases characterized by neurodegeneration. Lesions are microscopic only but in chronic disease with massive involvement there may be grossly visible atrophy of affected nervous tissue. and conditions associated with aging. To date the Company has focused on developing targeted anti-oxidant therapeutics for respiratory, neurological and cardiovascular diseases and the development of nutraceuticals and cosmeceuticals for the support of certain age related conditions. This press release contains, in addition to historical information, forward-looking statements that involve substantial risk and uncertainty. There can be no assurance that the opinions, beliefs or predictions contained in this press release regarding technologies or operations will be realized in whole or in part. Any restrictions or representations, written or oral, concerning the information contained herein, or opinions regarding future events are solely forward-looking and actual results may be materially different from predictions. There can be no assurance given to actual results of future events. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion